These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 383291

  • 1. Phase I evaluation of tetrahydrouridine combined with cytosine arabinoside.
    Wong PP, Currie VE, Mackey RW, Krakoff IH, Tan CT, Burchenal JH, Young CW.
    Cancer Treat Rep; 1979 Aug; 63(8):1245-9. PubMed ID: 383291
    [Abstract] [Full Text] [Related]

  • 2. Pharmacology of combination chemotherapy of cytosine arabinoside (ara-C) and uracil arabinoside (ara-U) or tetrahydrouridine (THU) against murine leukemia L1210/0 in tumor-bearing mice.
    Avramis VI, Powell W.
    Cancer Invest; 1987 Aug; 5(4):293-9. PubMed ID: 3664332
    [Abstract] [Full Text] [Related]

  • 3. Tetrahydrouridine: Physiologic disposition and effect upon deamination of cytosine arabinoside in man.
    Kreis W, Woodcock TM, Gordon CS, Krakoff IH.
    Cancer Treat Rep; 1977 Oct; 61(7):1347-53. PubMed ID: 589600
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Influence of tetrahydrouridine on the pharmacokinetics of intrathecally administered 1-beta-D-arabinofuranosylcytosine.
    Riccardi R, Chabner B, Glaubiger DL, Wood J, Poplack DG.
    Cancer Res; 1982 May; 42(5):1736-9. PubMed ID: 6896013
    [Abstract] [Full Text] [Related]

  • 9. Effect of tetrahydrouridine on metabolism and transport of 1-beta-D-arabinofuranosylcytosine in human cells.
    Riva C, Barra Y, Carcassonne Y, Cano JP, Rustum Y.
    Chemotherapy; 1992 May; 38(5):358-66. PubMed ID: 1286578
    [Abstract] [Full Text] [Related]

  • 10. [High-dose cytosine arabinoside treatment of leukemia with special reference to the optimal number of doses].
    Sampi K, Maseki N, Kumai R, Kaneko Y, Sakurai M, Hattori M.
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2595-8. PubMed ID: 2774589
    [Abstract] [Full Text] [Related]

  • 11. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
    Early AP, Preisler HD, Slocum H, Rustum YM.
    Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
    [Abstract] [Full Text] [Related]

  • 12. Phase I study of 5-fluorodeoxyuridine plus cytosine arabinoside infusions in patients with solid tumors.
    Cummings FJ, Hoovis ML, Calabresi P.
    Cancer Treat Rep; 1979 Aug; 63(8):1371-4. PubMed ID: 157808
    [Abstract] [Full Text] [Related]

  • 13. Thymidine as a kinetic and biochemical modulator of 1-beta-D-arabinofuranosylcytosine in human acute nonlymphocytic leukemia.
    Blumenreich MS, Chou TC, Andreeff M, Vale K, Clarkson BD, Young CW.
    Cancer Res; 1984 Feb; 44(2):825-30. PubMed ID: 6692380
    [Abstract] [Full Text] [Related]

  • 14. Therapy of refractory/relapsed acute myeloid leukemia and blast crisis of chronic myeloid leukemia with the combination of cytosine arabinoside, tetrahydrouridine, and carboplatin.
    Marsh JH, Kreis W, Barile B, Akerman S, Schulman P, Allen SL, DeMarco LC, Schuster MW, Budman DR.
    Cancer Chemother Pharmacol; 1993 Feb; 31(6):481-4. PubMed ID: 8453688
    [Abstract] [Full Text] [Related]

  • 15. [Intermediate- and high-dose cytosine arabinoside therapy in acute refractory leukemia].
    Ohshima A, Yoshida K, Sato T, Miyazaki S, Yanagisawa M, Nakayama Y, Takahashi T, Mamiya S, Fukusima Y, Miura AB.
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):192-5. PubMed ID: 3800405
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A single high dose of idarubicin combined with high-dose ARA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University "La Sapienza" of Rome.
    Testi AM, Moleti ML, Giona F, Annino L, Chiaretti S, Del Giudice I, Todisco E, D'Elia G, Ferrari A, Arcese W, Mandelli F.
    Haematologica; 1997 Jan; 82(6):664-7. PubMed ID: 9499665
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.